| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.04 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |